Your session is about to expire
← Back to Search
Dietary Supplement
Choline for Cardiovascular Risk
N/A
Waitlist Available
Led By Kevin Davy, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-hour test in laboratory at 4 timepoints; baseline, week 4, week 6, and week 10
Awards & highlights
Study Summary
This trial is looking at whether a metabolite produced by gut microbes, Trimethylamine-N-oxide (TMAO), is linked to increased risk of cardiovascular disease in humans. They will be supplementing participants with dietary choline to see if it has any effect on cardiovascular disease risk factors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-hour test in laboratory at 4 timepoints; baseline, week 4, week 6, and week 10
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-hour test in laboratory at 4 timepoints; baseline, week 4, week 6, and week 10
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Insulin Sensitivity after Supplementation
Secondary outcome measures
Glucose
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Choline supplementationActive Control1 Intervention
Participants will consume 1000 mg of choline per day for 4 weeks.
Group II: Placebo supplementationPlacebo Group1 Intervention
Participants will consume 1000 mg of placebo per day for 4 weeks.
Find a Location
Who is running the clinical trial?
Virginia Polytechnic Institute and State UniversityLead Sponsor
144 Previous Clinical Trials
27,813 Total Patients Enrolled
3 Trials studying Cardiovascular Risk
60 Patients Enrolled for Cardiovascular Risk
Kevin Davy, PhDPrincipal Investigator - Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute and State University
4 Previous Clinical Trials
102 Total Patients Enrolled
3 Trials studying Cardiovascular Risk
60 Patients Enrolled for Cardiovascular Risk
Share this study with friends
Copy Link
Messenger